FDA DEVICE FACTS
HALO
Nicolab B.V.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
HALO is a notification-only, cloud-based image-processing software application using artificial-intelligence algorithms to analyze patient imaging data in parallel to the standard-of-care imaging interpretation. Its intended use is to identify suggestive imaging patterns of a pre-specified clinical condition and to directly notify an appropriate medical specialist. HALO is indicated to facilitate evaluation of the brain vasculature in patients suspected of stroke by processing and analyzing CT angiograms of the brain acquired in an acute setting. After completion of data analysis, HALO sends a notification if a pattern suggestive of a suspected intracranial large vessel occlusion (LVO) of the anterior circulation (ICA, M1, or M2) has been identified in an image. The intended users are medical specialists or teams of specialists involved in the diagnosis and care of stroke patients in emergency departments or other departments where stroke patients are administered, including neurologists, radiologists, and/or other emergency-department physicians. HALO output should not be used for primary diagnosis or clinical decisions; final diagnosis is always decided by the medical specialist. HALO is indicated for CT scanners from GE Healthcare and Philips.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。